Interestingly, GLP-1 receptor agonists are used for the treatment of Type 2 diabetes mellitus (T2DM) and obesity, due to its ability to reduce blood glucose levels and lower body weight [54]. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.